tiprankstipranks
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Income Statement

Compare
2 Followers

MaaT Pharma Income Statement

Last quarter (Q2 2024), MaaT Pharma's total revenue was €1.72M, an increase of 149.78% from the same quarter last year. In Q2, MaaT Pharma's net income was €-12.86M. See MaaT Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 2.23M€ 1.43M€ 972.00K€ 0.00€ 89.30K
Gross Profit
€ 1.66M€ 1.09M€ 806.00K€ -164.00K€ -7.70K
Operating Expenses
€ 21.29M€ 14.65M€ 9.70M€ 5.25M€ 4.96M
Depreciation and Amortization
€ 871.00K€ 429.00K€ 328.00K€ 164.00K€ 97.00K
EBITDA
€ -19.74M€ -13.31M€ -8.71M€ -6.58M€ -6.76M
Operating Income
€ -19.94M€ -13.56M€ -8.89M€ -5.25M€ -4.96M
Other Income/Expenses
€ 226.00K€ -156.00K€ -126.00K€ -49.00K€ -879.00K
Pretax Income
€ -19.72M€ -13.71M€ -9.02M€ -5.30M€ -5.84M
Net Income
€ -19.72M€ -13.87M€ -9.14M€ -5.35M€ -6.65M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ -1.73€ -1.40€ -3.77€ -25.91€ -32.20
Diluted EPS
€ -1.73€ -1.40€ -3.77€ -25.91€ -32.20
Weighted Average Shares Outstanding
11.37M 9.89M 2.43M 206.46K 206.46K
Weighted Average Shares Outstanding (Diluted)
11.37M 9.89M 2.43M 206.46K 206.46K
Currency in EUR

MaaT Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis